Digital PCR (DPCR) and QPCR Market By Manufacturers, By Technology (Quantitative PCR (QPCR), Digital PCR (DPCR)), By Product (Reagents and Consumables, Instruments, Software), By Application (Clinical Applications, Research Applications, Forensic Applications), By End-User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391248 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Digital PCR (DPCR) and QPCR Market is valued USD 4.08 Billion in 2019 and is projected is to exhibit 8.67% CAGR during the forecast period. The market is projected to be around USD 7.30 Billion by 2026. The market is driven by the rising incidences of target diseases and genetic disorders, continuous technological advancements in PCR technologies.
Digital PCR (dPCR) is a quantitative PCR process that gives a sensitive and reproducible way of measuring the amount of RNA or DNA present in a sample. Polymerase chain reaction (PCR) expertise is used in a variety of applications ranging from DNA cloning, paternity testing, functional investigation of genes, detection of contagious diseases, diagnosis of hereditary diseases, and forensic sciences. Quantitative PCR (qPCR) and digital PCR (dPCR) are the two kinds of polymerase chain reaction (PCR) technologies.
Digital PCR (DPCR) and QPCR Market Dynamics
The major factors that drive the growth of the market are rising incidences of target diseases and genetic disorders, continuous technological advancements in PCR technologies, the development of miniaturized portable instruments, and incorporation of robotics. Furthermore, raising funds grants for research activities, increasing the use of bio-marker profiling for disease diagnostics, and the successful completion of the Human Genome Project.
Additionally, increasing improvements in PCR techniques and R&D activities that utilize PCR supplement market growth. At the same time, the high cost of instruments associated with dPCR and the limitations in the dPCR and qPCR techniques are supposed to hinder the growth of the digital PCR (dPCR) and qPCR market throughout the forecast period.
Digital PCR (DPCR) and QPCR Market Insight
Based on the region, the Asia-Pacific is expected to hold the largest market share in the digital PCR (DPCR) and QPCR market during the forecast period, due to the high prevalence of chronic and infectious diseases with growing awareness in the patients regarding early diagnosis of diseases is driving the demand for digital PCR and real-time PCR market.
Digital PCR (DPCR) and QPCR Market Segmentation
The global Digital PCR (DPCR) and QPCR Market is segmented into technology, product, application, end-user and region. On the basis of the technology the market is divided into quantitative PCR (QPCR), digital PCR (DPCR). Based on product the market is segmented into reagents and consumables, instruments, software. Based on application the market is segmented into clinical applications, research applications, and forensic applications. Based on end-user the market is segmented into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, forensic laboratories. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Digital PCR (DPCR) and QPCR Market Competitive Landscape
The key players in Digital PCR (DPCR) and QPCR Market are listed as Hoffman-La Roche Ltd., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Takara Bio, Inc., Agilent Technologies, Inc., Biomerieux S.A., Fluidigm Corporation, Danaher Corporation, ABBott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Meridian Bioscience, Inc. (Bioline Reagents Ltd.), Analytik Jena AG (Endress+Hauser Ag), Avance Biosciences, Eppendorf AG, Biodesix, Inc., F. Hoffmann-La Roche AG, JN Medsys, Quantabio, Siemens AG, and Other.
Digital PCR (dPCR) is a quantitative PCR process that gives a sensitive and reproducible way of measuring the amount of RNA or DNA present in a sample. Polymerase chain reaction (PCR) expertise is used in a variety of applications ranging from DNA cloning, paternity testing, functional investigation of genes, detection of contagious diseases, diagnosis of hereditary diseases, and forensic sciences. Quantitative PCR (qPCR) and digital PCR (dPCR) are the two kinds of polymerase chain reaction (PCR) technologies.
Digital PCR (DPCR) and QPCR Market Dynamics
The major factors that drive the growth of the market are rising incidences of target diseases and genetic disorders, continuous technological advancements in PCR technologies, the development of miniaturized portable instruments, and incorporation of robotics. Furthermore, raising funds grants for research activities, increasing the use of bio-marker profiling for disease diagnostics, and the successful completion of the Human Genome Project.
Additionally, increasing improvements in PCR techniques and R&D activities that utilize PCR supplement market growth. At the same time, the high cost of instruments associated with dPCR and the limitations in the dPCR and qPCR techniques are supposed to hinder the growth of the digital PCR (dPCR) and qPCR market throughout the forecast period.
Digital PCR (DPCR) and QPCR Market Insight
Based on the region, the Asia-Pacific is expected to hold the largest market share in the digital PCR (DPCR) and QPCR market during the forecast period, due to the high prevalence of chronic and infectious diseases with growing awareness in the patients regarding early diagnosis of diseases is driving the demand for digital PCR and real-time PCR market.
Digital PCR (DPCR) and QPCR Market Segmentation
The global Digital PCR (DPCR) and QPCR Market is segmented into technology, product, application, end-user and region. On the basis of the technology the market is divided into quantitative PCR (QPCR), digital PCR (DPCR). Based on product the market is segmented into reagents and consumables, instruments, software. Based on application the market is segmented into clinical applications, research applications, and forensic applications. Based on end-user the market is segmented into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, forensic laboratories. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Digital PCR (DPCR) and QPCR Market Competitive Landscape
The key players in Digital PCR (DPCR) and QPCR Market are listed as Hoffman-La Roche Ltd., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Takara Bio, Inc., Agilent Technologies, Inc., Biomerieux S.A., Fluidigm Corporation, Danaher Corporation, ABBott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Meridian Bioscience, Inc. (Bioline Reagents Ltd.), Analytik Jena AG (Endress+Hauser Ag), Avance Biosciences, Eppendorf AG, Biodesix, Inc., F. Hoffmann-La Roche AG, JN Medsys, Quantabio, Siemens AG, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Digital PCR (DPCR) and QPCR Market, By Technology
5.1. Digital PCR (DPCR) and QPCR Market, By Technology, 2018-2026
5.2. Quantitative PCR (qPCR)
5.3. Digital PCR (dPCR)Chapter 6. Digital PCR (DPCR) and QPCR Market, By Product
6.1. Digital PCR (DPCR) and QPCR Market, by Product, 2018-2026
6.2. Reagents and Consumables
6.3. Instruments
6.4. SoftwareChapter 7. Digital PCR (DPCR) and QPCR Market, By Application
7.1. Digital PCR (DPCR) and QPCR Market, By Application, 2018-2026
7.2. Clinical Applications
7.3. Research Applications
7.4. Forensic ApplicationsChapter 8. Digital PCR (DPCR) and QPCR Market, By End-User
8.1. Digital PCR (DPCR) and QPCR Market, by End-User, 2018-2026
8.2. Hospitals and Diagnostic Centers
8.4. Research Laboratories and Academic Institutes
8.6. 8.5. Pharmaceutical and Biotechnology Companies
8.7. Clinical Research Organizations
8.8. Forensic LaboratoriesChapter 9. Digital PCR (DPCR) and QPCR Market, By Region
9.1. Digital PCR (DPCR) and QPCR Market, by Region, 2018-2026
9.1.1. North America
9.1.1.1. U.S
9.1.1.2. Rest of North America
9.1.2. Europe
9.1.2.1. U.K.
9.1.2.2. Germany
9.1.2.3. France
9.1.2.4. Rest of the Europe
9.1.3. Middle East & Africa (MEA)
9.1.3.1. GCC
9.1.3.2. North Africa
9.1.3.3. South Africa
9.1.3.4. Rest of MEA
9.1.4. Latin America (LATAM)
9.1.4.1. Brazil
9.1.4.2. Rest of LATAM
9.1.5. Asia Pacific (APAC)
9.1.5.1. India
9.1.5.2. China
9.1.5.3. Japan
9.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 11. Company Profiles11.1. Hoffman-La Roche Ltd.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives11.4. Qiagen N.V.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives11.5 Takara Bio, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives11.7. Biomerieux S.A.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives11.8. Fluidigm Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives11.9. Danaher Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives11.10. ABBott Laboratories
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives11.11. Merck KGaA
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives11.12. Becton Dickinson and Company
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives11.13. Promega Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives11.14. Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives11.15 Analytik Jena AG (Endress+Hauser Ag)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives11.16. Avance Biosciences
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives11.17. Eppendorf AG
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives11.18. Biodesix, Inc.
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives11.21. F. Hoffmann-La Roche AG
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives11.20. JN Medsys
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance
11.20.4. Recent Initiatives11.21. Quantabio
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives11.22. Siemens AG
11.22.1. Company Overview
11.22.2. Product Offerings
11.22.3. Financial Performance
11.22.4. Recent Initiatives11.23. List of other companies
11.23.1. Company Overview
11.23.2. Product Offerings
11.23.3. Financial Performance
11.23.4. Recent InitiativesChapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Digital PCR (DPCR) and QPCR Market, By Technology
5.1. Digital PCR (DPCR) and QPCR Market, By Technology, 2018-2026
5.2. Quantitative PCR (qPCR)
5.3. Digital PCR (dPCR)Chapter 6. Digital PCR (DPCR) and QPCR Market, By Product
6.1. Digital PCR (DPCR) and QPCR Market, by Product, 2018-2026
6.2. Reagents and Consumables
6.3. Instruments
6.4. SoftwareChapter 7. Digital PCR (DPCR) and QPCR Market, By Application
7.1. Digital PCR (DPCR) and QPCR Market, By Application, 2018-2026
7.2. Clinical Applications
7.3. Research Applications
7.4. Forensic ApplicationsChapter 8. Digital PCR (DPCR) and QPCR Market, By End-User
8.1. Digital PCR (DPCR) and QPCR Market, by End-User, 2018-2026
8.2. Hospitals and Diagnostic Centers
8.4. Research Laboratories and Academic Institutes
8.6. 8.5. Pharmaceutical and Biotechnology Companies
8.7. Clinical Research Organizations
8.8. Forensic LaboratoriesChapter 9. Digital PCR (DPCR) and QPCR Market, By Region
9.1. Digital PCR (DPCR) and QPCR Market, by Region, 2018-2026
9.1.1. North America
9.1.1.1. U.S
9.1.1.2. Rest of North America
9.1.2. Europe
9.1.2.1. U.K.
9.1.2.2. Germany
9.1.2.3. France
9.1.2.4. Rest of the Europe
9.1.3. Middle East & Africa (MEA)
9.1.3.1. GCC
9.1.3.2. North Africa
9.1.3.3. South Africa
9.1.3.4. Rest of MEA
9.1.4. Latin America (LATAM)
9.1.4.1. Brazil
9.1.4.2. Rest of LATAM
9.1.5. Asia Pacific (APAC)
9.1.5.1. India
9.1.5.2. China
9.1.5.3. Japan
9.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 11. Company Profiles11.1. Hoffman-La Roche Ltd.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives11.4. Qiagen N.V.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives11.5 Takara Bio, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives11.7. Biomerieux S.A.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives11.8. Fluidigm Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives11.9. Danaher Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives11.10. ABBott Laboratories
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives11.11. Merck KGaA
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives11.12. Becton Dickinson and Company
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives11.13. Promega Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives11.14. Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives11.15 Analytik Jena AG (Endress+Hauser Ag)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives11.16. Avance Biosciences
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives11.17. Eppendorf AG
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives11.18. Biodesix, Inc.
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives11.21. F. Hoffmann-La Roche AG
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives11.20. JN Medsys
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance
11.20.4. Recent Initiatives11.21. Quantabio
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives11.22. Siemens AG
11.22.1. Company Overview
11.22.2. Product Offerings
11.22.3. Financial Performance
11.22.4. Recent Initiatives11.23. List of other companies
11.23.1. Company Overview
11.23.2. Product Offerings
11.23.3. Financial Performance
11.23.4. Recent InitiativesChapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Hoffman-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Takara Bio, Inc.
Agilent Technologies, Inc.
Biomerieux S.A.
Fluidigm Corporation
Danaher Corporation
ABBott Laboratories
Merck KGaA
Becton Dickinson and Company
Promega Corporation
Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
Analytik Jena AG (Endress+Hauser Ag)
Avance Biosciences
Eppendorf AG
Biodesix, Inc.
F. Hoffmann-La Roche AG
JN Medsys
Quantabio
Siemens AG
Other
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Takara Bio, Inc.
Agilent Technologies, Inc.
Biomerieux S.A.
Fluidigm Corporation
Danaher Corporation
ABBott Laboratories
Merck KGaA
Becton Dickinson and Company
Promega Corporation
Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
Analytik Jena AG (Endress+Hauser Ag)
Avance Biosciences
Eppendorf AG
Biodesix, Inc.
F. Hoffmann-La Roche AG
JN Medsys
Quantabio
Siemens AG
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com